These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2231066)

  • 1. Prevention of cardiovascular disease: risks and benefits of aspirin.
    Buring JE; Hennekens CH
    J Gen Intern Med; 1990; 5(5 Suppl):S54-7. PubMed ID: 2231066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin in chronic cardiovascular disease and acute myocardial infarction.
    Hennekens CH
    Clin Cardiol; 1990 Mar; Suppl 5():V62-6; discussion V67-72. PubMed ID: 2182244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin in the treatment and prevention of cardiovascular disease.
    Gaziano JM; Skerrett PJ; Buring JE
    Haemostasis; 2000; 30 Suppl 3():1-13. PubMed ID: 11182624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet agents in the prevention of cardiovascular morbidity and mortality in older patients with vascular disease.
    Aronow WS
    Drugs Aging; 1999 Aug; 15(2):91-101. PubMed ID: 10495069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Am Heart J; 1999 Apr; 137(4 Pt 2):S9-S13. PubMed ID: 10097241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.
    Berger JS; Roncaglioni MC; Avanzini F; Pangrazzi I; Tognoni G; Brown DL
    JAMA; 2006 Jan; 295(3):306-13. PubMed ID: 16418466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An update on aspirin in the primary prevention of cardiovascular disease.
    Eidelman RS; Hebert PR; Weisman SM; Hennekens CH
    Arch Intern Med; 2003 Sep; 163(17):2006-10. PubMed ID: 14504112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
    Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
    JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin in the treatment and prevention of cardiovascular disease.
    Hennekens CH
    Annu Rev Public Health; 1997; 18():37-49. PubMed ID: 9143711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.
    BMJ; 1994 Jan; 308(6921):81-106. PubMed ID: 8298418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin in the treatment and prevention of cardiovascular disease: current perspectives and future directions.
    Hennekens CH
    Curr Atheroscler Rep; 2007 Nov; 9(5):409-16. PubMed ID: 18001625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease.
    De Schryver EL; Algra A; van Gijn J
    Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.
    Aronow WS
    Geriatrics; 2007 Apr; 62(4):12-24. PubMed ID: 17408314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antiplatelet drugs in secondary prevention in patients with atherothrombotic disease.
    Aronow WS
    Compr Ther; 2006; 32(3):182-8. PubMed ID: 17435272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet therapy in the treatment of cerebrovascular disease.
    Couch JR
    Clin Cardiol; 1993 Oct; 16(10):703-10. PubMed ID: 8222382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose aspirin in patients with stable cardiovascular disease: a meta-analysis.
    Berger JS; Brown DL; Becker RC
    Am J Med; 2008 Jan; 121(1):43-9. PubMed ID: 18187072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet therapy and risk of stroke.
    Hennekens CH; Jonas MA; Buring JE
    Ann Epidemiol; 1993 Sep; 3(5):568-70. PubMed ID: 8167839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of antiplatelet drugs in secondary prevention in older persons with atherothrombotic disease.
    Aronow WS
    J Gerontol A Biol Sci Med Sci; 2007 May; 62(5):518-24. PubMed ID: 17522356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.